(1)
Putri, D. A.; Setiawan, D.; Yamsun, M. Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-Mutation Colorectal Cancer. Pharm. : j. farm. Indones. 2025, 22, 6-11.